Effects of the standardised ginseng extract G115® in patients with chronic bronchitis: A nonblinded, randomised, comparative pilot study

Clinical Drug Investigation

Volumn 21, Issue 1, 2001, Pages 41-45

  Scaglione, F ^a   Weiser, K ^a   Alessandria, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; GINSENG EXTRACT; HERBACEOUS AGENT;

ADULT; ARTICLE; BACTERIAL COUNT; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; ITALY; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZATION; STATISTICS; TREATMENT OUTCOME;

EID: 0035150849     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121010-00006     Document Type: Article

References (10)

1. Immunomodulatory activity of Panax ginseng extract
2. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
3. The role of infection during exacerbation of chronic bronchitis
4. Bacterial infections in chronic obstructive pulmonary disease
5. Combined treatment of mice with Panax ginseng extract and interferon inducer
6. Immunomodulatory effects of two extracts of Panax ginseng C.A
7. Efficacy and safety of the standardised ginseng extract G 115® for potentiating vaccination against common cold and/or influenza syndrome
8. Immunomodulatory effects of Panax ginseng C.A. Meyer (G115®) on alveolar macrophages from patients suffering with chronic bronchitis
9. Ginseng extract G115® for the treatment of chronic respiratory diseases
10. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats